Journal
CLINICAL CANCER RESEARCH
Volume 19, Issue 12, Pages 3111-3113Publisher
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1078-0432.CCR-13-0800
Keywords
-
Categories
Funding
- NIH [R01 CA142794]
- AACR-Kure It Grant for Kidney Cancer Research
Ask authors/readers for more resources
There is a need for the discovery of novel therapeutic strategies to effectively treat advanced clear cell renal cell carcinoma (ccRCC). Inhibition of stearoyl-coA desaturase 1 (SCD1) in ccRCC reveals antitumor activity, independently and in synergy with mTOR inhibition. SCD1 may be a potential novel therapeutic target in treating ccRCC. (C)2013 AACR.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
